Combined pharmaceutical composition for treating small cell lung cancer
US-12527784-B2 · Jan 20, 2026 · US
Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group holds 7 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 7 |
| Recent patents | 5 |
| First publication | Jun 9, 2022 |
| Latest publication | Jan 20, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12527784-B2 · Jan 20, 2026 · US
US-12421313-B2 · Sep 23, 2025 · US
US-2025282873-A1 · Sep 11, 2025 · US
US-2024269278-A1 · Aug 15, 2024 · US
US-2023405141-A1 · Dec 21, 2023 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12527784-B2 · Jan 20, 2026 · US
US-12421313-B2 · Sep 23, 2025 · US
US-2025282873-A1 · Sep 11, 2025 · US
US-2024269278-A1 · Aug 15, 2024 · US
US-2023405141-A1 · Dec 21, 2023 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 7 |
| A61K2039/505 | 6 |
| C07K16/2827 | 4 |
| A61K39/3955 | 4 |
| A61K45/06 | 4 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 7 |
| Chemistry & Metallurgy | 7 |
Answers are generated from the same data shown on this page.